gender issues

Sex, clinical trials and medicines regulation part III

Thursday, January 19, 2017 - 11:01

Gender issue in clinical trials in Europe

Internationally, the issue of including women in clinical trials of medicines has been addressed in various guidelines issued by the International Conference on Harmonization (ICH), which promotes regulatory standards for clinical trials. While ICH has specific guidelines on the conduct of clinical trials in paediatric and geriatric populations, there are no consolidated guidelines for the investigation of medicinal product in women.

Target: 
Government and Public Health, Healthcare Professionals
Topic: 
Gender, Human Rights, Policy, Stakeholders
Tags: 
gender issues, clinical trials, policy, transparency

Sex, clinical trials and medicines regulation part II

Friday, December 30, 2016 - 10:24

Drug Approval Regulation in Canada and USA

Since the thalidomide tragedy in the late1950s, there has been a reluctance to include women of childbearing age in clinical trials. However, this fear cannot be used as an excuse to not include females in clinical trials, and, with proper care and regulation, increased female participation has been reached. The United States adopted regulation early on to increase the participation of women, while a new regulation in Europe is going to improve this as well. Here follows an overview of the issue in Canada and in the USA. The third part of this series will deal with new regulation in Europe.

Target: 
Decision Makers, Government and Public Health
Topic: 
Gender, Prevention, Stakeholders, Treatment, Vaccination
Tags: 
gender issues, clinical trials

Sex, clinical trials and medicines regulation: part I

Monday, November 28, 2016 - 14:39

Attention to sex and gender in biomedical, health and clinical research is an important quality and safety issue. Medicinal products are safer and more effective for everyone when clinical research includes diverse population groups. Historically, women’s health issues have focused on reproductive health, followed by gender issues such as behaviour, socio-economic factors, culture, lifestyles and influence biological development and health.

Target: 
Government and Public Health, Healthcare Professionals
Topic: 
Gender, Prevention, Treatment, Vaccination
Tags: 
gender issues, clinical trials, Vaccine

A first glance at ASSET citizen consultation

Saturday, October 29, 2016 - 10:23

Citizens across Europe participated to the daylong citizen consultations organized by the ASSET project at the end of September.

Target: 
Citizens, Decision Makers, Government and Public Health
Topic: 
Citizens' Mobilization, Local Activities, Stakeholders, Vaccination
Tags: 
citizen consultation, gender issues, Vaccine, science-in-society, communication

Paper series 1 - Science for and with Society aiming to the public health emergencies response and preparedness

Tuesday, August 30, 2016 - 14:56

Athena Linos, European Institute of Women’s Health, Alberto d’Onofrio

Target: 
Citizens, Decision Makers, Government and Public Health, Healthcare Professionals
Topic: 
Epidemiology, Gender, Vaccination
Tags: 
science-in-society, gender issues, Vaccine, flu, influenza, behaviour, mathematics
PDF icon paper_series_1_-_science_for_and_with_society_aiming_to_the_public_health_emergencies_response_and_preparedness.pdf

Consider sex in clinical trials

July 13, 2016

Many clinical trials, even those on vaccines, are currently being made without considering the immunological differences that can exist between men and women. Katie Flanagan, senior lecturer of the Department of Immunology at Monash University, in Melbourne, Australia, explains how, and why this needs to be changed.

Target: 
Healthcare Professionals
Topic: 
Gender
Tags: 
Video, gender issues, clinical trials

Is Zika epidemic a lose-lose game for WHO?

Thursday, February 4, 2016 - 09:02

Declaring an emergency is a dirty work, but someone has to do it. When facing a serious threat to global public health, even if complete evidence is lacking, someone has to take the responsibility to push the red button that activates a chain of coordinated actions (such as cooperation among states and research on vaccines). Choosing to do this, the risk of giving a false alarm is unavoidable.

Target: 
Citizens, Decision Makers, Government and Public Health, Healthcare Professionals
Topic: 
Epidemiology, Gender, Human Rights, Media, Prevention
Tags: 
zika, H1N1, risk communication, Risk perception, WHO, gender issues, CDC

Looking at Zika from a gender perspective

Monday, January 25, 2016 - 16:32

The Zika virus has been recently identified in Europe after having spread in Brazil, where its first infection was confirmed in March 2015. Despite being relatively mild, this virus is now making headlines, as it could be responsible of a large increase of microcephaly among infants. A connection that pushed Brazil to declare Zika a public health emergency.

Target: 
Citizens, Government and Public Health, Healthcare Professionals
Topic: 
Epidemiology, Gender
Tags: 
zika, outbreak, gender issues

Raising awareness on gender issues in epidemics and pandemics

Friday, December 18, 2015 - 18:56

The consideration of sex and gender are not the most obvious issues that come to mind when discussing epidemics and pandemics. However, sex and gender have an important impact on these issues, since barriers to pandemic preparedness and risk behaviour can often be better understood when viewed from a sex and gender perspective.

Both gender and sex have an impact on experiences and behaviours relating to pandemics, epidemics and vaccination. The difference between sex and gender can be confusing, and the two words are often incorrectly used interchangeably.

Target: 
Citizens, Decision Makers, Government and Public Health, Healthcare Professionals, School and Education
Topic: 
Citizens' Mobilization, Gender, Human Rights, Policy, Stakeholders, Vaccination
Tags: 
gender issues, Preparedness, awareness, Risk perception

Pages

Subscribe to gender issues

MMLAP and other EU Projects

AsiaFluCap
Health system analysis to support capacity development in response to the threat of pandemic influenza in Asia
BEWATER
Making society an active participant in water adaptation to global change
CASI
Public Participation in Developing a Common Framework for Assessment and Management of Sustainable Innovation
CIMULACT
Engaging all of Europe in shaping a desirable and sustainable future
DARWIN
Expect the unexpected and know how to respond
DRIVER
Driving innovation in crisis management for European resilience
ECOM
Effective communication in outbreak management: development of an evidence-based tool for Europe
EDEN
Solutions to improve CBRNe resilience
EPISOUTH
Network for Communicable Disease Control in Southern Europe and Mediterranean Countries
EPIWORK
Developing the framework for an epidemic forecast infrastructure
EUPHARE
Strengthening of the national surveillance system for communicable diseases
EUROHEP
Surveillance of vaccine preventable hepatitis
EuroMOMO
European monitoring of excess mortality for public health action
EURONHID
European network for highly infectious disease
EUVAC.NET
Dedicated surveillance network for surveillance and control of vaccine preventable diseases in the EU
FLUMODCONT
Modelling the spread of pandemic influenza and strategies for its containment and mitigation
FLURESP
Cost-effectiveness assessment of european influenza human pandemic alert and response strategies
GAP2
Bridging the gap between science, stakeholders and policy makers
HProImmune
Promotion of immunization for health professionals in Europe
INPROFOOD
Towards inclusive research programming for sustainable food innovations
JA-CHRODIS
Addressing chronic diseases and healthy ageing across the life cycle
M-Eco
Medical ecosystem – personalized event-based surveillance
MAPPING
Studying the many and varied economic, social, legal and ethical aspects of the recent developments on the Internet, and their consequences for the individual and society at large
MARINA
Get involved in the responsible marine research and innovation
PACITA
Knowledge-based policy-making on issues involving science, technology and innovation, mainly based upon the practices in Parliamentary Technology Assessment
PANDEM
Assessment of the current pandemic preparedness and response tools, systems and practice at national, EU and global level in priority areas
PE2020
Analysis of innovative public engagement tools and instruments for dynamic governance in the field of Science in Society
PERARES
Public Engagement with Research And Research Engagement with Society
PHEME
Computing Veracity – the Fourth Challenge of Big Data
PREPARE
Providing infrastructure, co-ordination and integration of existing clinical research networks on epidemics and pandemics
PROMOVAX
Promote vaccinations among migrant population in Europe
R&DIALOGUE
Creating mechanisms for effectively tackling the scientific and technology related challenges faced by society
RESPIRE
Improve the quality of indoor air, keeping it free from radon
SATORI
Improving respect of ethics principles and laws in research and innovation, in line with the evolution of technologies and societal concerns
SECURING CITIES AGAINST GLOBAL PANDEMICS
Investigating how cities in the West securitise against global pandemics
SEiSMiC
Creating a structured dialogue and mutual learning with citizens and urban actors by setting up National Networks in 10 countries across Europe
SIS CATALYST
Identifying how children can be change agents in the Science and Society relationship
SYN-ENERGENE
Establishing an open dialogue between stakeholders concerning synthetic biology’s potential benefits and risks
TELLME
Transparent communication in Epidemics: Learning Lessons from experience, delivering effective Messages, providing Evidence